ArticleObesity surgery2026

Roux-en-Y Gastric Bypass Compared to Glucagon-Like Peptide-1 Receptor Agonists is Associated with Lower Out-of-Pocket Costs in Insured Patients with Type 2 Diabetes and Obesity: A Matched Analysis Over Two Years.

Sibi Thiyagarajan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.